Clinical trial
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
To evaluate the efficacy and safety of 0.5 mg in adult patients with visual impairment due to macular edema (ME).
| Category | Value |
|---|---|
| Study start date | 2013-04-30 |